Ginkgo Bioworks Holdings (DNA) Other Non-Current Liabilities (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Other Non-Current Liabilities data on file, last reported at $21.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 40.84% year-over-year to $21.7 million; the trailing twelve-month figure through Mar 2026 stood at $21.7 million (up 40.84% YoY), and the FY2025 full-year result was $22.9 million, up 38.01% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $21.7 million, down from $22.9 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $50.8 million in Q1 2022 and bottomed at $10.9 million in Q4 2022.
• The 5-year median for Other Non-Current Liabilities is $20.9 million (2024), against an average of $23.5 million.
• The widest annual swing landed in 2022, when Other Non-Current Liabilities tumbled 80.99%; it then jumped 124.82% in 2023.
• A 5-year view of Other Non-Current Liabilities shows it stood at $10.9 million in 2022, then soared by 124.82% to $24.4 million in 2023, then sank by 32.16% to $16.6 million in 2024, then soared by 38.01% to $22.9 million in 2025, then declined by 5.0% to $21.7 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $21.7 million (Q1 2026), $22.9 million (Q4 2025), and $17.2 million (Q3 2025), per Business Quant data.

Peer Comparison